1.
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
by Asche, Carl
Clinical therapeutics, 2011, Vol.33 (1), p.74-109

2.
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised...
by Griffin, Simon J, Dr
The Lancet (British edition), 2011, Vol.378 (9786), p.156-167

3.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

4.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
by Ray, Kausik K, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1765-1772

5.
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
by Simmons, Rebecca K, PhD
The Lancet (British edition), 2012, Vol.380 (9855), p.1741-1748

6.
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients
by Eeg-Olofsson, K
Diabetologia, 2008-11-05, Vol.52 (1), p.65-73

7.
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
by Jiang, Ying
European journal of epidemiology, 2011-01-01, Vol.26 (11), p.863-876

8.
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes : a prospective observational study (UKPDS 75)
by STRATTON, I. M
Diabetologia, 2006, Vol.49 (8), p.1761-1769

9.
Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
by Ranc, Kristina
Diabetologia, 2014-03-15, Vol.57 (5), p.927-934

10.

11.
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
by Renehan, A. G
Diabetologia, 2012-04-04, Vol.55 (6), p.1619-1632

12.
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome : an epidemiological cohort study
by MARTIN, S
Diabetologia, 2006, Vol.49 (2), p.271-278

13.
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus
by Hillis, G. S
Diabetologia, 2012-01-29, Vol.55 (5), p.1283-1290

14.
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic...
by Wild, Robert A
The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2038-2049

15.
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes : a comparison of patients treated with sulfonylureas and metformin
by EVANS, J. M. M
Diabetologia, 2006, Vol.49 (5), p.930-936

16.
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Eve...
by Drury, P. L
Diabetologia, 2010-07-30, Vol.54 (1), p.32-43

17.
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
by Imai, E
Diabetologia, 2011-10-13, Vol.54 (12), p.2978-2986

18.
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Ins...
by Mellbin, L. G
Diabetologia, 2011-02-26, Vol.54 (6), p.1308-1317

19.
The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis
by Brownrigg, J. R. W
Diabetologia, 2012-08-14, Vol.55 (11), p.2906-2912

20.
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
by Blin, P
Diabetologia, 2012-01-06, Vol.55 (3), p.644-653
